Ralph Dr. Kern - 06 Mar 2022 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
COO and Chief Medical Officer
Signature
/s/ Ralph Kern
Issuer symbol
BCLI
Transactions as of
06 Mar 2022
Net transactions value
$0
Form type
4
Filing time
14 Mar 2022, 20:00:52 UTC
Previous filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +35,885 +19% $0.000000 223,310 06 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of March 6, 2022, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date.